Hospira, Inc. (NYSE:HSP)

CAPS Rating: 2 out of 5

A specialty pharmaceutical and medication delivery company that is focused on products that improve the productivity, safety and efficacy of patient care.

Recs

0
Player Avatar bradford86 (99.43) Submitted: 1/7/2012 9:37:46 PM : Outperform Start Price: $30.36 HSP Score: +3.45

233. Hospira Inc. (NYSE: HSP) is cheap after it got murdered down from the $50's. With EPS guidance of $2.95 ballpark, this is a P/E of around 11 at present. Target: $35-$40. I think that we saw some end of year tax loss selling and that's all in the past. Clear the way for higher prices. I'm voting on this with CAPS points.

http://beta.fool.com/bradford86/2012/01/07/price-market-part-32/

Report this Post Reply

Featured Broker Partners


Advertisement